youtube_live
Q3 2026 earnings • released • EPS beat +7,77% • Revenue beat +2,95%
See resultschevron_right
GH:NASDAQ
Guardant Health Inc
150,62 USD
arrow_downward
-1,83%(-2,81) 1D
6-ноя., 15:34:04 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
141,83 USD
High
151,81 USD
Low
136,42 USD
Mkt. cap
19,96 млд
Avg. vol.
1,86 млн
Volume
4,26 млн
52-wk high
191,01 USD
52-wk low
74,55 USD
EPS
-3,50 USD
Beta
1,67
Shares outstanding
134,20 млн
No. of employees
2 миң
Open
141,83 USD
High
151,81 USD
Low
136,42 USD
Mkt. cap
19,96 млд
Avg. vol.
1,86 млн
Volume
4,26 млн
52-wk high
191,01 USD
52-wk low
74,55 USD
EPS
-3,50 USD
Beta
1,67
Shares outstanding
134,20 млн
No. of employees
2 миң
News stories
From web sources and news partners
GuruFocus
·
2 саат мурун
Guardant Health Stocks Fall 9.49% as Cash Burn Outlook Rises Des
Investor's Business Daily
·
5 саат мурун
Blood-Testing Gore Continues As Natera, Guardant Report
Investing.com
·
9 саат мурун
Guardant Health stock reiterated at Buy by BTIG after Q3 beat
Zacks
·
19 саат мурун
Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 миң
Founded2012
HeadquartersПало Альто, Калифорния, Америка Кошмо Штаттары
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com